MAP2K1 and neuroblastoma: NF1 gene expression, but not MEK1 or MEK2 gene expression, was strongly associated with patient outcomes in neuroblastoma and appeared to have prognostic effects independent of tumor stage (Fig. 4; Additional file 3).